VYNE Therapeutics Inc. (VYNE)

USD 1.37

(2.24%)

Revenue Summary of VYNE Therapeutics Inc.

  • VYNE Therapeutics Inc.'s latest annual revenue in 2023 was 424 Thousand USD , down -11.11% from previous year.
  • VYNE Therapeutics Inc.'s latest quarterly revenue in 2024 Q2 was 198 Thousand USD , up 102.04% from previous quarter.
  • VYNE Therapeutics Inc. reported a annual revenue of 477 Thousand USD in annual revenue 2022, down -96.77% from previous year.
  • VYNE Therapeutics Inc. reported a annual revenue of 14.75 Million USD in annual revenue 2021, down -29.71% from previous year.
  • VYNE Therapeutics Inc. reported a quarterly revenue of 198 Thousand USD for 2024 Q2, up 102.04% from previous quarter.
  • VYNE Therapeutics Inc. reported a quarterly revenue of 114 Thousand USD for 2023 Q3, down -15.56% from previous quarter.

Annual Revenue Chart of VYNE Therapeutics Inc. (2023 - 2015)

Historical Annual Revenue of VYNE Therapeutics Inc. (2023 - 2015)

Year Revenue Revenue Growth
2023 424 Thousand USD -11.11%
2022 477 Thousand USD -96.77%
2021 14.75 Million USD -29.71%
2020 20.99 Million USD 4638.83%
2019 443 Thousand USD -95.84%
2018 10.64 Million USD 132.21%
2017 4.58 Million USD 579.82%
2016 674 Thousand USD 0.0%
2015 - USD 0.0%

Peer Revenue Comparison of VYNE Therapeutics Inc.

Name Revenue Revenue Difference
Absci Corporation 5.71 Million USD 92.585%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.751%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.977%
Alzamend Neuro, Inc. - USD -Infinity%
Apollomics, Inc. 821 Thousand USD 48.356%
180 Life Sciences Corp. - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
Bicycle Therapeutics plc 26.97 Million USD 98.428%
Barinthus Biotherapeutics plc 802 Thousand USD 47.132%
BioXcel Therapeutics, Inc. 1.38 Million USD 69.275%
CASI Pharmaceuticals, Inc. 33.87 Million USD 98.748%
Chimerix, Inc. 324 Thousand USD -30.864%
CRISPR Therapeutics AG 371.2 Million USD 99.886%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 99.152%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 99.079%
Fortress Biotech, Inc. 84.51 Million USD 99.498%
Fortress Biotech, Inc. 84.51 Million USD 99.498%
Gritstone bio, Inc. 1.33 Million USD 68.144%
Allakos Inc. - USD -Infinity%
Boundless Bio, Inc. Common Stock - USD -Infinity%
Cara Therapeutics, Inc. 20.96 Million USD 97.978%
Cytokinetics, Incorporated 7.53 Million USD 94.369%
enGene Holdings Inc. Common Stock - USD -Infinity%
Innoviva, Inc. 310.46 Million USD 99.863%
Hoth Therapeutics, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Terns Pharmaceuticals, Inc. - USD -Infinity%
Vigil Neuroscience, Inc. - USD -Infinity%
ImmuCell Corporation 17.47 Million USD 97.573%
IDEAYA Biosciences, Inc. 23.38 Million USD 98.187%
Incyte Corporation 3.69 Billion USD 99.989%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD 49.039%
Lexaria Bioscience Corp. 226.2 Thousand USD -87.438%
Mustang Bio, Inc. - USD -Infinity%
MiMedx Group, Inc. 321.47 Million USD 99.868%
MEI Pharma, Inc. 65.29 Million USD 99.351%
MacroGenics, Inc. 58.74 Million USD 99.278%
Monopar Therapeutics Inc. - USD -Infinity%
Mereo BioPharma Group plc 10 Million USD 95.76%
Marker Therapeutics, Inc. 3.31 Million USD 87.195%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 98.632%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.853%
Minerva Neurosciences, Inc. - USD -Infinity%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
NextCure, Inc. - USD -Infinity%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 84.638%
Ocuphire Pharma, Inc. 19.04 Million USD 97.774%
Onconetix, Inc. 58.46 Thousand USD -625.22%
Oncternal Therapeutics, Inc. 785 Thousand USD 45.987%
Opthea Limited 261.85 Thousand USD -61.919%
Ovid Therapeutics Inc. 391.69 Thousand USD -8.247%
Psyence Biomedical Ltd. - USD -Infinity%
PDS Biotechnology Corporation - USD -Infinity%
Precigen, Inc. 6.22 Million USD 93.189%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 99.01%
Prime Medicine, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 87.267%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.997%
Replimune Group, Inc. - USD -Infinity%
Revelation Biosciences, Inc. - USD -Infinity%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.637%
TransCode Therapeutics, Inc. - USD -Infinity%
Revolution Medicines, Inc. Warrant 11.58 Million USD 96.339%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 98.94%
Sangamo Therapeutics, Inc. 176.23 Million USD 99.759%
Solid Biosciences Inc. - USD -Infinity%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
SciSparc Ltd. 2.87 Million USD 85.273%
Sutro Biopharma, Inc. 153.73 Million USD 99.724%
TG Therapeutics, Inc. 233.66 Million USD 99.819%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 94.542%
Titan Pharmaceuticals, Inc. 184 Thousand USD -130.435%
Travere Therapeutics, Inc. 145.23 Million USD 99.708%
UroGen Pharma Ltd. 82.71 Million USD 99.487%
Verrica Pharmaceuticals Inc. 5.12 Million USD 91.725%
XOMA Corporation 4.75 Million USD 91.089%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
AbCellera Biologics Inc. 38.02 Million USD 98.885%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
Cassava Sciences, Inc. - USD -Infinity%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Precision BioSciences, Inc. 48.72 Million USD 99.13%
Dyadic International, Inc. 2.89 Million USD 85.373%
Intensity Therapeutics, Inc. - USD -Infinity%
Eton Pharmaceuticals, Inc. 31.64 Million USD 98.66%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 80.094%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Acelyrin, Inc. - USD -Infinity%
Abeona Therapeutics Inc. 3.5 Million USD 87.886%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.677%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD -62.764%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.731%
Syros Pharmaceuticals, Inc. 9.93 Million USD 95.733%
Senti Biosciences, Inc. 2.56 Million USD 83.444%
Mesoblast Limited 5.9 Million USD 92.816%
Kymera Therapeutics, Inc. 78.59 Million USD 99.461%
ChromaDex Corporation 83.57 Million USD 99.493%
BriaCell Therapeutics Corp. - USD -Infinity%
Akebia Therapeutics, Inc. 194.62 Million USD 99.782%
Dermata Therapeutics, Inc. - USD -Infinity%
Seer, Inc. 15.18 Million USD 97.207%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.741%
Novavax, Inc. 983.7 Million USD 99.957%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Fate Therapeutics, Inc. 63.53 Million USD 99.333%
Checkpoint Therapeutics, Inc. 103 Thousand USD -311.65%
Lyell Immunopharma, Inc. 130 Thousand USD -226.154%
Celcuity Inc. - USD -Infinity%
ContextLogic Inc. 287 Million USD 99.852%
Phathom Pharmaceuticals, Inc. 682 Thousand USD 37.83%
HOOKIPA Pharma Inc. 20.12 Million USD 97.894%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.989%
Amarin Corporation plc 306.91 Million USD 99.862%
AnaptysBio, Inc. 17.15 Million USD 97.529%
Aptevo Therapeutics Inc. - USD -Infinity%
Aptorum Group Limited 431.37 Thousand USD 1.71%
Cartesian Therapeutics, Inc. 26 Million USD 98.369%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.824%
Ardelyx, Inc. 124.45 Million USD 99.659%
Celularity Inc. 22.77 Million USD 98.138%
Omeros Corporation - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Immunocore Holdings plc 249.42 Million USD 99.83%
IO Biotech, Inc. - USD -Infinity%
GT Biopharma, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -8380.0%
Pulmatrix, Inc. 7.29 Million USD 94.19%
Intellia Therapeutics, Inc. 36.27 Million USD 98.831%
Evogene Ltd. 5.64 Million USD 92.482%
CorMedix Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 91.167%
VistaGen Therapeutics, Inc. 1.06 Million USD 60.15%
Sagimet Biosciences Inc. 2 Million USD 78.8%
PTC Therapeutics, Inc. 937.82 Million USD 99.955%
scPharmaceuticals Inc. 13.59 Million USD 96.881%
Fulcrum Therapeutics, Inc. 2.8 Million USD 84.884%
Corcept Therapeutics Incorporated 482.37 Million USD 99.912%
NLS Pharmaceutics AG - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Akero Therapeutics, Inc. - USD -Infinity%
Eliem Therapeutics, Inc. - USD -Infinity%
Lisata Therapeutics, Inc. - USD -Infinity%
Stoke Therapeutics, Inc. 8.78 Million USD 95.171%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Outlook Therapeutics, Inc. - USD -Infinity%
ProMIS Neurosciences, Inc. - USD -Infinity%
Daré Bioscience, Inc. 2.8 Million USD 84.9%
bluebird bio, Inc. 29.49 Million USD 98.563%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.982%
DBV Technologies S.A. 15.72 Million USD 97.304%
Avidity Biosciences, Inc. 9.56 Million USD 95.565%
Galecto, Inc. - USD -Infinity%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Spruce Biosciences, Inc. 10.08 Million USD 95.797%
Inhibrx Biosciences, Inc. 1.8 Million USD 76.444%
GlycoMimetics, Inc. 10 Thousand USD -4140.0%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 99.289%
ADMA Biologics, Inc. 258.21 Million USD 99.836%
Clene Inc. 654 Thousand USD 35.168%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 99.049%
Aptose Biosciences Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD 49.485%
Century Therapeutics, Inc. 2.23 Million USD 81.029%
Kura Oncology, Inc. - USD -Infinity%
Surrozen, Inc. - USD -Infinity%
TScan Therapeutics, Inc. 21.04 Million USD 97.986%
Ocean Biomedical, Inc. - USD -Infinity%
CytomX Therapeutics, Inc. 101.21 Million USD 99.581%
Autolus Therapeutics plc 1.69 Million USD 75.029%
Mineralys Therapeutics, Inc. - USD -Infinity%
Eterna Therapeutics Inc. 68 Thousand USD -523.529%
Caribou Biosciences, Inc. 34.47 Million USD 98.77%
GRI Bio, Inc. 21.76 Million USD 98.052%
Xenetic Biosciences, Inc. 2.53 Million USD 83.307%
Janux Therapeutics, Inc. 8.08 Million USD 94.754%
INmune Bio, Inc. 155 Thousand USD -173.548%
Heron Therapeutics, Inc. 127.04 Million USD 99.666%
SAB Biotherapeutics, Inc. 2.23 Million USD 81.063%
Pasithea Therapeutics Corp. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Jaguar Health, Inc. 9.76 Million USD 95.656%
Entero Therapeutics, Inc. - USD -Infinity%
Milestone Pharmaceuticals Inc. 1 Million USD 57.6%
Clearside Biomedical, Inc. 8.22 Million USD 94.846%
Atara Biotherapeutics, Inc. 8.57 Million USD 95.054%
Coherus BioSciences, Inc. 257.24 Million USD 99.835%
Verastem, Inc. - USD -Infinity%
Pliant Therapeutics, Inc. 1.58 Million USD 73.165%
Histogen Inc. 3.76 Million USD 88.75%
Aprea Therapeutics, Inc. 583.23 Thousand USD 27.302%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.942%
Surrozen, Inc. - USD -Infinity%
Organovo Holdings, Inc. 109 Thousand USD -288.991%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 93.813%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
BioRestorative Therapies, Inc. 145.8 Thousand USD -190.809%
Kronos Bio, Inc. 6.28 Million USD 93.257%
Turnstone Biologics Corp. 19.3 Million USD 97.804%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Entrada Therapeutics, Inc. 129.01 Million USD 99.671%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.758%
Exelixis, Inc. 1.83 Billion USD 99.977%
Nurix Therapeutics, Inc. 76.98 Million USD 99.449%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.893%
Jasper Therapeutics, Inc. - USD -Infinity%
ESSA Pharma Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.697%
Insmed Incorporated 305.2 Million USD 99.861%
MediWound Ltd. 18.68 Million USD 97.731%
OmniAb, Inc. 34.16 Million USD 98.759%
Alector, Inc. 97.06 Million USD 99.563%
Seres Therapeutics, Inc. 126.32 Million USD 99.664%
Zai Lab Limited 266.71 Million USD 99.841%
AlloVir, Inc. - USD -Infinity%
Revance Therapeutics, Inc. 234.04 Million USD 99.819%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
Aura Biosciences, Inc. - USD -Infinity%
Immunic, Inc. - USD -Infinity%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 97.57%
Veracyte, Inc. 361.05 Million USD 99.883%
InMed Pharmaceuticals Inc. 4.59 Million USD 90.778%
FibroGen, Inc. 147.75 Million USD 99.713%
SeaStar Medical Holding Corporation - USD -Infinity%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.894%
Adial Pharmaceuticals, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -186.864%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD -0.952%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.889%
Fortrea Holdings Inc. 3.1 Billion USD 99.986%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
XBiotech Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Keros Therapeutics, Inc. 151 Thousand USD -180.795%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD 72.786%
Foghorn Therapeutics Inc. 34.15 Million USD 98.759%
Agenus Inc. 156.31 Million USD 99.729%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 99.5%
Theravance Biopharma, Inc. 57.42 Million USD 99.262%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.902%
Metagenomi, Inc. Common Stock 44.75 Million USD 99.053%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.872%
Gain Therapeutics, Inc. 55.18 Thousand USD -668.394%
C4 Therapeutics, Inc. 20.75 Million USD 97.957%
Creative Medical Technology Holdings, Inc. 9000.00 USD -4611.111%
Chemomab Therapeutics Ltd. - USD -Infinity%
Lantern Pharma Inc. - USD -Infinity%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
Ainos, Inc. 122.11 Thousand USD -247.222%
Pluri Inc. 326 Thousand USD -30.061%
Prothena Corporation plc 91.37 Million USD 99.536%
Adaptimmune Therapeutics plc 60.28 Million USD 99.297%
Rallybio Corporation - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
Cue Biopharma, Inc. 5.49 Million USD 92.277%
MeiraGTx Holdings plc 14.01 Million USD 96.975%
Annexon, Inc. - USD -Infinity%
Assembly Biosciences, Inc. 7.16 Million USD 94.081%
Moderna, Inc. 6.84 Billion USD 99.994%
Cocrystal Pharma, Inc. - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 99.337%
Blueprint Medicines Corporation 249.38 Million USD 99.83%
Immix Biopharma, Inc. - USD -Infinity%
CalciMedica, Inc. - USD -Infinity%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Scholar Rock Holding Corporation - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 99.626%
Sana Biotechnology, Inc. - USD -Infinity%
Elicio Therapeutics, Inc. - USD -Infinity%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 91.513%
Nutriband Inc. 2.08 Million USD 79.667%
Protara Therapeutics, Inc. - USD -Infinity%
Vor Biopharma Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 99.66%
Alkermes plc 1.66 Billion USD 99.975%
ProKidney Corp. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 95.757%
Arcellx, Inc. 110.31 Million USD 99.616%
BridgeBio Pharma, Inc. 9.3 Million USD 95.442%
Tango Therapeutics, Inc. 36.52 Million USD 98.839%
Galectin Therapeutics Inc. - USD -Infinity%
Atai Life Sciences N.V. 314 Thousand USD -35.032%
Renovaro Biosciences Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
MediciNova, Inc. 1 Million USD 57.6%
Praxis Precision Medicines, Inc. 2.44 Million USD 82.673%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -2384.618%
GeoVax Labs, Inc. - USD -Infinity%
Axsome Therapeutics, Inc. 270.6 Million USD 99.843%
Biomea Fusion, Inc. - USD -Infinity%
RenovoRx, Inc. - USD -Infinity%
Cullinan Oncology, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD -78.903%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 97.954%
Dyne Therapeutics, Inc. - USD -Infinity%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.843%
Royalty Pharma plc 2.35 Billion USD 99.982%
Ventyx Biosciences, Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
BioAtla, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -346.316%
Larimar Therapeutics, Inc. - USD -Infinity%
Mersana Therapeutics, Inc. 36.85 Million USD 98.85%
Structure Therapeutics Inc. - USD -Infinity%
89bio, Inc. - USD -Infinity%
Kezar Life Sciences, Inc. 7 Million USD 93.943%
aTyr Pharma, Inc. 353 Thousand USD -20.113%
Aligos Therapeutics, Inc. 15.52 Million USD 97.27%
Viridian Therapeutics, Inc. 314 Thousand USD -35.032%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -3416.046%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.949%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 64.784%
Liquidia Corporation 17.48 Million USD 97.575%
Entera Bio Ltd. - USD -Infinity%
GH Research PLC - USD -Infinity%
Vericel Corporation 197.51 Million USD 99.785%
Arbutus Biopharma Corporation 18.14 Million USD 97.663%
Xencor, Inc. 168.33 Million USD 99.748%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD -67.21%
Pasithea Therapeutics Corp. - USD -Infinity%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.78%
Lexaria Bioscience Corp. 226.2 Thousand USD -87.438%
Portage Biotech Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -2384.618%
Olema Pharmaceuticals, Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD 71.79%
Qualigen Therapeutics, Inc. 5.2 Million USD 91.854%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
Sol-Gel Technologies Ltd. 1.55 Million USD 72.716%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 99.452%
CollPlant Biotechnologies Ltd. 10.95 Million USD 96.131%
Moleculin Biotech, Inc. - USD -Infinity%
United Therapeutics Corporation 2.32 Billion USD 99.982%
HilleVax, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -488.056%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.827%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Pyxis Oncology, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. - USD -Infinity%
Windtree Therapeutics, Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 95.77%
Carmell Therapeutics Corporation - USD -Infinity%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.983%
Protagonist Therapeutics, Inc. 60 Million USD 99.293%
Erasca, Inc. - USD -Infinity%
Protagenic Therapeutics, Inc. - USD -Infinity%
Protagenic Therapeutics, Inc. - USD -Infinity%
Vincerx Pharma, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 94.704%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Celldex Therapeutics, Inc. 6.88 Million USD 93.84%
Cogent Biosciences, Inc. - USD -Infinity%
Adicet Bio, Inc. - USD -Infinity%
Amicus Therapeutics, Inc. 399.35 Million USD 99.894%
Aditxt, Inc. 645.17 Thousand USD 34.281%
Adagene Inc. 18.11 Million USD 97.659%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 60.813%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 250 Million USD 99.83%
Compugen Ltd. 33.45 Million USD 98.733%
Generation Bio Co. 5.9 Million USD 92.818%
Astria Therapeutics, Inc. - USD -Infinity%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Invivyd, Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 98.34%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 99.562%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 99.578%
Instil Bio, Inc. - USD -Infinity%
Capricor Therapeutics, Inc. 25.17 Million USD 98.316%
Elevai Labs, Inc. Common Stock 1.71 Million USD 75.242%
GeoVax Labs, Inc. - USD -Infinity%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Relmada Therapeutics, Inc. - USD -Infinity%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 99.508%
Evaxion Biotech A/S 73.11 Thousand USD -479.932%
Ocular Therapeutix, Inc. 58.44 Million USD 99.275%
Verve Therapeutics, Inc. 11.75 Million USD 96.394%
Tyra Biosciences, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Bolt Biotherapeutics, Inc. 7.87 Million USD 94.617%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
ImmunityBio, Inc. 622 Thousand USD 31.833%
Korro Bio, Inc. - USD -Infinity%
Kineta, Inc. 5.44 Million USD 92.209%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 99.396%
Celularity Inc. 22.77 Million USD 98.138%
Aileron Therapeutics, Inc. - USD -Infinity%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 89.434%
Virax Biolabs Group Limited 156.41 Thousand USD -171.067%
Cibus, Inc. 1.81 Million USD 76.665%
IN8bio, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 88.222%
Avalo Therapeutics, Inc. 1.92 Million USD 77.963%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.946%
Eyenovia, Inc. 3787.00 USD -11096.198%
Puma Biotechnology, Inc. 235.63 Million USD 99.82%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Elevation Oncology, Inc. - USD -Infinity%
Xilio Therapeutics, Inc. - USD -Infinity%
Cardiff Oncology, Inc. 488 Thousand USD 13.115%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 99.465%
Regulus Therapeutics Inc. - USD -Infinity%
Moolec Science SA 905.04 Thousand USD 53.152%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
LAVA Therapeutics N.V. 6.76 Million USD 93.736%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Compass Therapeutics, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD 42.224%
Humacyte, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Genelux Corporation 170 Thousand USD -149.412%
Trevi Therapeutics, Inc. - USD -Infinity%
Notable Labs, Ltd. 310 Thousand USD -36.774%
Immunovant, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 60.813%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 77.229%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Soleno Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Nuvectis Pharma, Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Belite Bio, Inc - USD -Infinity%
XOMA Corporation 4.75 Million USD 91.089%
ARS Pharmaceuticals, Inc. 30 Thousand USD -1313.333%
Bionomics Limited - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
uniQure N.V. 15.84 Million USD 97.324%
Estrella Immunopharma, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 99.345%
Forte Biosciences, Inc. - USD -Infinity%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Altimmune, Inc. 426 Thousand USD 0.469%
LENZ Therapeutics, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -15.256%
Zevra Therapeutics, Inc. 27.46 Million USD 98.456%
Benitec Biopharma Inc. 216 Thousand USD -96.296%
Spyre Therapeutics, Inc. 886 Thousand USD 52.144%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Zura Bio Limited - USD -Infinity%
PolyPid Ltd. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
argenx SE 1.22 Billion USD 99.965%
Immunome, Inc. 14.01 Million USD 96.975%
Verona Pharma plc - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD 74.412%
CervoMed Inc. 7.14 Million USD 94.066%
Plus Therapeutics, Inc. 4.91 Million USD 91.37%
Dianthus Therapeutics, Inc. 2.82 Million USD 84.996%
Moolec Science SA 905.04 Thousand USD 53.152%
Enveric Biosciences, Inc. - USD -Infinity%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
Seelos Therapeutics, Inc. 2.2 Million USD 80.754%
Achilles Therapeutics plc - USD -Infinity%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD -107.843%
Fractyl Health, Inc. Common Stock 120 Thousand USD -253.333%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Tourmaline Bio, Inc. - USD -Infinity%
Beam Therapeutics Inc. 377.7 Million USD 99.888%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.773%
AEON Biopharma, Inc. - USD -Infinity%
Aadi Bioscience, Inc. 24.35 Million USD 98.259%
Enliven Therapeutics, Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
NeurAxis, Inc. 2.46 Million USD 82.765%
Iovance Biotherapeutics, Inc. 1.18 Million USD 64.34%
Lumos Pharma, Inc. 2.05 Million USD 79.327%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 98.959%
Palisade Bio, Inc. 250 Thousand USD -69.6%
Nutriband Inc. 2.08 Million USD 79.667%
Taysha Gene Therapies, Inc. 15.45 Million USD 97.256%
Neurogene Inc. - USD -Infinity%
Kintara Therapeutics, Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Athira Pharma, Inc. - USD -Infinity%
HCW Biologics Inc. 2.84 Million USD 85.08%
XOMA Corporation 4.75 Million USD 91.089%
Nektar Therapeutics 90.12 Million USD 99.53%
Arvinas, Inc. 78.5 Million USD 99.46%
Tevogen Bio Holdings Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 99.035%
Omega Therapeutics, Inc. 3.09 Million USD 86.296%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD 35.168%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 75.785%
Synlogic, Inc. 3.37 Million USD 87.422%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -15.256%
Werewolf Therapeutics, Inc. 19.94 Million USD 97.874%
Krystal Biotech, Inc. 50.69 Million USD 99.164%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.71%
SpringWorks Therapeutics, Inc. 5.44 Million USD 92.216%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD 5.698%
MannKind Corporation 198.96 Million USD 99.787%
Ikena Oncology, Inc. 9.16 Million USD 95.371%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 99.626%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.851%
Mural Oncology plc - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 99.155%
REGENXBIO Inc. 90.24 Million USD 99.53%
Ensysce Biosciences, Inc. 2.23 Million USD 80.991%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 94.254%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD 43.841%
Longeveron Inc. 709 Thousand USD 40.197%
Repare Therapeutics Inc. 51.13 Million USD 99.171%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.966%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 96.339%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD -101.905%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.996%
Denali Therapeutics Inc. 330.53 Million USD 99.872%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 97.398%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 84.314%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -178.16%
Carisma Therapeutics, Inc. 14.91 Million USD 97.158%
Unicycive Therapeutics, Inc. 675 Thousand USD 37.185%
OmniAb, Inc. 34.16 Million USD 98.759%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 98.005%
Lipocine Inc. -2.85 Million USD 114.873%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 81.063%
G1 Therapeutics, Inc. 82.51 Million USD 99.486%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 99.51%
Ocugen, Inc. 6.03 Million USD 92.975%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD 63.322%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 98.825%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 92.936%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Dominari Holdings Inc. 2.03 Million USD 79.205%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.963%
Agios Pharmaceuticals, Inc. 26.82 Million USD 98.419%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.927%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 96.634%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD 11.111%
Iterum Therapeutics plc - USD -Infinity%